ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Alamar Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$26.30+1.02 (+4.03%)
Close on Oct 19, 2026
- Market cap
- $1.54B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
7 of Alamar Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 28, 2026 | Sep 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 20, 2026 | SEC EDGAR |